Using the Micropublications ontology and the Open Annotation Data Model to represent evidence within a drug-drug interaction knowledge base

CEUR Workshop Proceedings

Volumn 1282, Issue , 2014, Pages 60-70

  Schneider, Jodi ^a   Ciccarese, Paolo ^b   Clark, Tim ^b   Boyce, Richard D ^c  

^a INRIA   (France)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Drug drug interactions; Evidence bases; Knowledge bases; Linked data; Micropublications; Open annotation data model

Indexed keywords

KNOWLEDGE BASED SYSTEMS; KNOWLEDGE REPRESENTATION; LINKED DATA; MICROFORMS; ONTOLOGY; OPEN DATA; SEMANTIC WEB;

DRUG-DRUG INTERACTIONS; EVIDENCE BASES; KNOWLEDGE BASIS; MEDICATION ERRORS; MEDICATION SAFETY; MICROPUBLICATIONS; SEMANTIC WEB MODELS; SEMANTIC WEB TECHNOLOGY;

DRUG INTERACTIONS;

EID: 84939530374     PISSN: 16130073     EISSN: None     Source Type: Conference Proceeding    
DOI: None     Document Type: Conference Paper

References (12)

1. [Abarca2003] Abarca, Jacob, Daniel C. Malone, Edward P. Armstrong, Amy J. Grizzle, Philip D. Hansten, Robin C. Van Bergen, and Richard B. Lipton. "Concordance of severity ratings provided in four drug interaction compendia." Journal of the American Pharmacists Association 44;2 (2003): 136-141.
2. [Boyce2014] Boyce, R.D. "A Draft Evidence Taxonomy and Inclusion Criteria for the Drug Interaction Knowledge Base." August 9, 2014, url: http://purl.net/net/druginteraction-knowledge-base/evidence-types-and-inclusion-criteria.
3. [Boyce2007] Boyce, Richard D., Carol Collins, John Horn, and Ira Kalet. "Modeling Drug Mechanism Knowledge Using Evidence and Truth Maintenance." IEEE Transactions on Information Technology in Biomedicine 11;4 (2007): 386-397.
4. [Boyce2009] Boyce, Richard D., Carol Collins, John Horn, and Ira Kalet. "Computing with evidence: Part I: A drug-mechanism evidence taxonomy oriented toward confidence assignment." Journal of Biomedical Informatics 42;6 (2009): 979-989.
5. [Ciccarese2008] Ciccarese, Paolo N., Elizabeth Wu, Gwen Wong, Marco Ocana, June Kinoshita, Alan Ruttenberg, and Tim Clark. "The SWAN biomedical discourse ontology." Journal of Biomedical Informatics 41;5 (2008): 739-751.
6. [Ciccarese2014] Ciccarese, Paolo N., Marco Ocana, and Tim Clark. "Open semantic annotation of scientific publications using DOMEO." Journal of Biomedical Semantics Apr 24;3 (2012): Suppl 1:S1.
7. [Clark2014] Clark, Tim, Paolo N. Ciccarese, and Carole A. Goble. "Micropublications: A semantic model for claims, evidence, arguments and annotations in biomedical communications." Journal of Biomedical Semantics 5;28 (2014).
8. [Hanna2013] Hanna, Josh, Eric Joseph, Mathias Brochhausen, and William R. Hogan. "Building a drug ontology based on RxNorm and other sources." Journal of Biomedical Semantics 4 (2013): 44-52.
9. [Natale2011] Natale, Darren A., Cecilia N. Arighi, Winona C. Barker, Judith A. Blake, Carol J. Bult, Michael Caudy, Harold J. Drabkin, Peter D'Eustachio, Alexei V. Evsikov, Hongzhan Huang, Jules Nchoutmboube, Natalia V. Roberts, Barry Smith, Jian Zhang and Cathy H. Wu. "The Protein Ontology: A structured representation of protein forms and complexes." Nucleic acids research 39, no. suppl 1 (2011): D539- D545.
10. [Saverno2011] Saverno, Kim R., Lisa E. Hines, Terri L. Warholak, Amy J. Grizzle, Lauren Babits, Courtney Clark, Ann M. Taylor, and Daniel C. Malone. "Ability of pharmacy clinical decision-support software to alert users about clinically important drug-drug interactions." Journal of the American Medical Informatics Association 18;1 (2011): 32-37.
11. [Wang2010] Wang, Lorraine M., Maple Wong, James M. Lightwood, and Christine M. Cheng. "Black box warning contraindicated comedications: concordance among three major drug interaction screening programs." Annals of Pharmacotherapy 44; 1 (2010): 28-34.
12. [W3C2013] Sanderson, Rob, Paolo N. Ciccarese, and Herbert Van de Sompel (editors). "Open Annotation Data Model", W3C Community Group Draft, 08 February 2013, url: http://www.openannotation.org/spec/core/.